Skip to main content
Sign In

We are a nationally recognized department of Ophthalmology.

Othamology Banner Image
 

Scott C N Oliver, MD

Assistant Professor


Director, Eye Cancer Program
Department of Ophthalmology
University of Colorado School of Medicine
Anschutz Medical Campus
1675 Aurora Court, Mail Stop F-731
Aurora, CO  80045

Appointments:  (720) 848-2020

Curriculum Vitae

Dr. Oliver specializes in the management of retinal diseases and tumors of the eye, including expertise in macular degeneration, diabetic retinopathy, retinal vein and artery occlusion, retinal detachment, macular hole, macular pucker, retinopathy of prematurity, choroidal melanoma and retinoblastoma. 
 
Dr. Oliver is an investigator in national clinical trials and in basic science research.  His research interests include improving treatment for choroidal melanoma, macular degeneration, and diabetic eye disease.

EYE CONDITIONS:

Diabetic retinopathy, Retinal detachment, Age-related macular degeneration, Retinal vascular disease, Retinal vein occlusion, Proliferative vitreoretinopathy, Complications of cataract surgery, Macular hole, Epiretinal membrane, Retinopathy of prematurity, Choroidal melanoma, Retinoblastoma, Intraocular tumors.

EYE TREATMENTS:

Laser photocoagulation, Vitrectomy, Scleral buckling, Plaque brachytherapy.

ENROLLING STUDIES:

Anti-PDGF Combination Injection for New Wet Macular Degeneration

Ocriplasmin for Injection for Wet Macular Degeneration and Vitreomacular Adhesion

ACTIVE STUDIES:

HARBOR - high dose ranibizumab for wet-AMD

RISE - ranibizumab for DME

 

PRIOR STUDIES:

AART - anecortave acetate for wet amd
BRAVO - ranibizumab for BRVO
CRUISE - ranibizumab for CRVO
HORIZON - ranibizumab extension study for wet-AMD and RVO
MIVI-TRUST 006 - microplasmin for VMT
Posurdex DME
Posurdex RVO
Fenretinide for GA in AMD
Thrombogenics MIVI III - microplasmin before surgical vitrectomy
ORION - ranibizumab for NAION

EDUCATION:

  • Medical School: University of Colorado School of Medicine
  • Residency: Ophthalmology, University of Colorado School of Medicine
  • Fellowship: Vitreoretinal Surgery and Disease, Ophthalmic Oncology, Jules Stein Eye Institute, University of California Los Angeles

AWARDS:

2011  Academic Faculty Teaching Award, Department of Ophthalmology, University of Colorado

2011  Nomination, President’s Award for World Class Care, University of Colorado Hospital

2008 Fellow’s Teaching Award, Jules Stein Eye Institute, UCLA

2005-2006 Elected Chief Resident, Department of Ophthalmology, University of Colorado Denver

2003 Intern of the Year, Exempla Saint Joseph Hospital, Denver, CO

2002 Alpha Omega Alpha, University of Colorado

1998 Phi Beta Kappa, Trinity University

1994 Eagle Scout

PUBLICATIONS:   Scott C N Oliver, MD